Subsequent malignant neoplasms after hematopoietic cell transplantation.
作者信息
Socié Gerard, Baker K Scott, Bhatia Smita
机构信息
Hematology Transplantation, APHP Hospital Saint Louis and University Paris VII Denis Diderot, Paris, France.
出版信息
Biol Blood Marrow Transplant. 2012 Jan;18(1 Suppl):S139-50. doi: 10.1016/j.bbmt.2011.10.005.
Abstract
摘要
相似文献
1
Subsequent malignant neoplasms after hematopoietic cell transplantation.
Biol Blood Marrow Transplant. 2012 Jan;18(1 Suppl):S139-50. doi: 10.1016/j.bbmt.2011.10.005.
2
Second malignancies after allogeneic hematopoietic stem cell transplantation: new insight and current problems.
Blood Rev. 2002 Jun;16(2):135-46. doi: 10.1054/blre.2002.0010.
3
Myelodysplastic syndromes complicating hematopoietic stem cell transplantation.
Cancer Treat Res. 2001;108:169-84. doi: 10.1007/978-1-4615-1463-3_10.
4
Risk factors for therapy-related myelodysplastic syndrome and acute myeloid leukemia treated with allogeneic stem cell transplantation.
Haematologica. 2009 Apr;94(4):542-9. doi: 10.3324/haematol.2008.000927. Epub 2009 Mar 10.
5
[Secondary solid tumor and late mortality after allogeneic hematopoietic stem cell transplantation].
Rinsho Ketsueki. 2014 Jul;55(7):785-8.
6
Fatal Kaposi sarcoma after allogeneic stem cell transplant.
Leuk Lymphoma. 2011 Dec;52(12):2402-4. doi: 10.3109/10428194.2011.593275. Epub 2011 Jul 12.
7
Second solid tumors: screening and management guidelines in long-term survivors after allogeneic stem cell transplantation.
Semin Hematol. 2012 Jan;49(1):4-9. doi: 10.1053/j.seminhematol.2011.10.013.
8
Allogeneic hematopoietic stem cell transplantation: an option for long-term survival for patients with simultaneous appearance of myeloid and lymphatic malignancies.
Acta Haematol. 2013;129(3):135-6. doi: 10.1159/000343422. Epub 2012 Nov 29.
9
A case report of secondary oral squamous cell carcinoma after allogeneic hematopoietic stem cell transplantation.
Oral Oncol. 2020 Oct;109:104629. doi: 10.1016/j.oraloncology.2020.104629. Epub 2020 Mar 9.
10
Comparison of outcomes after allogeneic hematopoietic stem cell transplantation in patients with follicular lymphoma, diffuse large B-cell lymphoma associated with follicular lymphoma, or de novo diffuse large B-cell lymphoma.
Am J Hematol. 2012 Aug;87(8):770-5. doi: 10.1002/ajh.23246. Epub 2012 May 28.
引用本文的文献
1
Exploring the aftermath of hematopoietic cell transplantation: 18-year insights into post-transplant neoplasms.
Front Oncol. 2025 Jul 22;15:1589755. doi: 10.3389/fonc.2025.1589755. eCollection 2025.
2
Clonal hematopoiesis and risk of nonmyeloid subsequent malignant neoplasms after autologous hematopoietic cell transplantation.
J Natl Cancer Inst. 2025 Sep 1;117(9):1925-1933. doi: 10.1093/jnci/djaf181.
3
Assessment of Survivorship in Allogeneic Hematopoietic Stem Cell Transplantation.
Methods Mol Biol. 2025;2907:91-125. doi: 10.1007/978-1-0716-4430-0_5.
4
Incidence and outcomes of subsequent malignancy after allogeneic hematopoietic stem cell transplantation in adult patients with severe aplastic anemia.
Blood Res. 2024 Dec 24;59(1):44. doi: 10.1007/s44313-024-00046-2.
5
Genotype and Associated Cancer Risk in Individuals With Telomere Biology Disorders.
JAMA Netw Open. 2024 Dec 2;7(12):e2450111. doi: 10.1001/jamanetworkopen.2024.50111.
6
International recommendations for screening and preventative practices for long-term survivors of transplantation and cellular therapy: a 2023 update.
Bone Marrow Transplant. 2024 Jun;59(6):717-741. doi: 10.1038/s41409-023-02190-2. Epub 2024 Feb 27.
7
International Recommendations for Screening and Preventative Practices for Long-Term Survivors of Transplantation and Cellular Therapy: A 2023 Update.
Transplant Cell Ther. 2024 Apr;30(4):349-385. doi: 10.1016/j.jtct.2023.12.001. Epub 2024 Feb 27.
8
Risk of Secondary Malignancies in Hematopoietic Stem Cell Transplantation Recipients: A Nationwide Population-Based Study in Taiwan.
Balkan Med J. 2023 Mar 8;40(2):131-138. doi: 10.4274/balkanmedj.galenos.2023.2022-10-56. Epub 2023 Feb 22.
9
Selection bias in follow-up studies of stem cell transplantation survivors: an experience within the Maastricht Observational study of late effects after Stem cell trAnsplantation (MOSA).
Ann Hematol. 2023 Mar;102(3):641-649. doi: 10.1007/s00277-022-05070-9. Epub 2022 Dec 31.
10
Linking the Center for International Blood and Marrow Transplant Research Registry to the California Cancer Registry and California Hospital Patient Discharge Data.
Transplant Cell Ther. 2022 Dec;28(12):859.e1-859.e10. doi: 10.1016/j.jtct.2022.09.016. Epub 2022 Sep 27.
本文引用的文献
1
Variants at 6q21 implicate PRDM1 in the etiology of therapy-induced second malignancies after Hodgkin's lymphoma.
Nat Med. 2011 Jul 24;17(8):941-3. doi: 10.1038/nm.2407.
2
Long-term survival and late deaths after allogeneic hematopoietic cell transplantation.
J Clin Oncol. 2011 Jun 1;29(16):2230-9. doi: 10.1200/JCO.2010.33.7212. Epub 2011 Apr 4.
3
Factors associated with adherence to preventive care practices among hematopoietic cell transplantation survivors.
Biol Blood Marrow Transplant. 2011 Jul;17(7):995-1003. doi: 10.1016/j.bbmt.2010.10.023. Epub 2010 Dec 8.
4
Secondary solid cancers after allogeneic hematopoietic cell transplantation using busulfan-cyclophosphamide conditioning.
Blood. 2011 Jan 6;117(1):316-22. doi: 10.1182/blood-2010-07-294629. Epub 2010 Oct 6.
5
Life expectancy in patients surviving more than 5 years after hematopoietic cell transplantation.
J Clin Oncol. 2010 Feb 20;28(6):1011-6. doi: 10.1200/JCO.2009.25.6693. Epub 2010 Jan 11.
6
Allogeneic transplantation for therapy-related myelodysplastic syndrome and acute myeloid leukemia.
Blood. 2010 Mar 4;115(9):1850-7. doi: 10.1182/blood-2009-10-249128. Epub 2009 Dec 23.
7
Lymphoproliferative disorders and de novo malignancies in intestinal and multivisceral recipients: improved outcomes with new outlooks.
Transplantation. 2009 Oct 15;88(7):926-34. doi: 10.1097/TP.0b013e3181b7509c.
8
Genome-wide association study to identify novel loci associated with therapy-related myeloid leukemia susceptibility.
Blood. 2009 May 28;113(22):5575-82. doi: 10.1182/blood-2008-10-183244. Epub 2009 Mar 18.
9
Basal cell skin cancer after total-body irradiation and hematopoietic cell transplantation.
Radiat Res. 2009 Feb;171(2):155-63. doi: 10.1667/RR1469.1.
10
Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation.
Blood. 2009 May 14;113(20):4992-5001. doi: 10.1182/blood-2008-09-178046. Epub 2009 Mar 5.
Zotero 插件